tiprankstipranks
Eli Lilly launches weight-loss drug Mounjaro in India, Reuters says
PremiumThe FlyEli Lilly launches weight-loss drug Mounjaro in India, Reuters says
5d ago
Hims & Hers to keep offering compounded Ozempic, Wegovy, WSJ reports
Premium
The Fly
Hims & Hers to keep offering compounded Ozempic, Wegovy, WSJ reports
5d ago
Eli Lilly (LLY) Leads India’s Weight-Loss Drug Race with Mounjaro
Premium
Market News
Eli Lilly (LLY) Leads India’s Weight-Loss Drug Race with Mounjaro
5d ago
Oppenheimer biotech analyst holds an analyst/industry conference call
PremiumThe FlyOppenheimer biotech analyst holds an analyst/industry conference call
8d ago
Positive Outlook for Eli Lilly & Co. Amid FDA Support and Strong Revenue Projections
Premium
Ratings
Positive Outlook for Eli Lilly & Co. Amid FDA Support and Strong Revenue Projections
8d ago
FDA voices ‘concerns’ with unapproved GLP-1 drugs used for weight loss
Premium
The Fly
FDA voices ‘concerns’ with unapproved GLP-1 drugs used for weight loss
8d ago
Citi Sticks to Sell Rating on Hims & Hers (HIMS) Stock as FDA Ruling Clouds Outlook
PremiumMarket NewsCiti Sticks to Sell Rating on Hims & Hers (HIMS) Stock as FDA Ruling Clouds Outlook
14d ago
Novo Nordisk (NVO) Sinks after Weight-Loss Drug Trial Misses Expectations
Premium
Market News
Novo Nordisk (NVO) Sinks after Weight-Loss Drug Trial Misses Expectations
15d ago
Novo Nordisk under pressure as obesity drug disappoints in diabetes trial
Premium
The Fly
Novo Nordisk under pressure as obesity drug disappoints in diabetes trial
15d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100